Literature DB >> 15896313

Akt1 contains a functional leucine-rich nuclear export sequence.

Motoyasu Saji1, Vasily Vasko, Faiza Kada, Elena Hardy Allbritton, Kenneth D Burman, Matthew D Ringel.   

Abstract

Nuclear Akt1 expression and Akt activation are common in cancer invasion. However, the mechanisms for this association and its causal role in invasion are uncertain. In an effort to identify potential mechanisms for regulating Akt subcellular localization, we analyzed the Akt gene sequences and identified a highly conserved leucine-rich potential nuclear export sequence (NES). Initial experiments demonstrated that leptomycin B induced nuclear Akt1 localization. Transient expression experiments demonstrated that, in comparison to wild-type Akt1, NES-mutated (AKT/NES) Akt1 has reduced interactions with CRM-1 and persistent nuclear localization. Subsequent stable transfection experiments in Akt1-/- fibroblasts confirmed that expression of AKT/NES resulted in persistent nuclear localization and activation1. Finally, stable expression of AKT/NES in Akt1-/- fibroblasts was sufficient to enhance cell migration in vitro. Thus, Akt1 contains a functional NES and mutation of the NES results in nuclear-predominant Akt1 activation that is sufficient to induce migration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15896313     DOI: 10.1016/j.bbrc.2005.04.109

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  37 in total

1.  Regulation of actin function by protein kinase A-mediated phosphorylation of Limk1.

Authors:  Kiran S Nadella; Motoyasu Saji; Naduparambil K Jacob; Emilia Pavel; Matthew D Ringel; Lawrence S Kirschner
Journal:  EMBO Rep       Date:  2009-05-08       Impact factor: 8.807

Review 2.  Nuclear and mitochondrial signalling Akts in cardiomyocytes.

Authors:  Shigeki Miyamoto; Marta Rubio; Mark A Sussman
Journal:  Cardiovasc Res       Date:  2009-03-11       Impact factor: 10.787

3.  Cardioprotective stimuli mediate phosphoinositide 3-kinase and phosphoinositide dependent kinase 1 nuclear accumulation in cardiomyocytes.

Authors:  Marta Rubio; Daniele Avitabile; Kimberlee Fischer; Gregory Emmanuel; Natalie Gude; Shigeki Miyamoto; Shikha Mishra; Eric M Schaefer; Joan Heller Brown; Mark A Sussman
Journal:  J Mol Cell Cardiol       Date:  2009-03-06       Impact factor: 5.000

4.  Inhibition of CtBP1 activity by Akt-mediated phosphorylation.

Authors:  Jacqueline C Merrill; Michael H Kagey; Tiffany A Melhuish; Shannon E Powers; Brad J Zerlanko; David Wotton
Journal:  J Mol Biol       Date:  2010-03-31       Impact factor: 5.469

Review 5.  Role of AKT signaling in DNA repair and clinical response to cancer therapy.

Authors:  Qun Liu; Kristen M Turner; W K Alfred Yung; Kexin Chen; Wei Zhang
Journal:  Neuro Oncol       Date:  2014-05-07       Impact factor: 12.300

6.  Integrin-linked kinase cytoplasmic and nuclear expression in laryngeal carcinomas.

Authors:  Anastasios K Goulioumis; Vasiliki Bravou; John Varakis; Panos Goumas; Helen Papadaki
Journal:  Virchows Arch       Date:  2008-09-24       Impact factor: 4.064

7.  Identification of functional domains in AKT responsible for distinct roles of AKT isoforms in pressure-stimulated cancer cell adhesion.

Authors:  Shouye Wang; Marc D Basson
Journal:  Exp Cell Res       Date:  2007-08-16       Impact factor: 3.905

8.  Physical association of PDK1 with AKT1 is sufficient for pathway activation independent of membrane localization and phosphatidylinositol 3 kinase.

Authors:  Zhiyong Ding; Jiyong Liang; Jin Li; Yiling Lu; Vathsala Ariyaratna; Zhimin Lu; Michael A Davies; John K Westwick; Gordon B Mills
Journal:  PLoS One       Date:  2010-03-26       Impact factor: 3.240

9.  PTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden syndrome.

Authors:  Xin He; Motoyasu Saji; Deepa Radhakrishnan; Todd Romigh; Joanne Ngeow; Qi Yu; Yu Wang; Matthew D Ringel; Charis Eng
Journal:  J Clin Endocrinol Metab       Date:  2012-09-07       Impact factor: 5.958

10.  Potential effects of CRM1 inhibition in mantle cell lymphoma.

Authors:  Ke-Jie Zhang; Michael Wang
Journal:  Chin J Cancer Res       Date:  2012-12       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.